Prevention trials

This series provides an overview of the increasing amount of research focusing on tackling Alzheimers disease as early as possible as well as preventing its onset in presymptomatic subjects.

Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4

Authors: Daniel A Pollen, Stephen Baker, Douglas Hinerfeld, Joan Swearer, Barbara A Evans, James E Evans, Richard Caselli, Ekaterina Rogaeva, Peter St George-Hyslop and Majaz Moonis

Citation: Alzheimer's Research & Therapy 2010 2:31

Content type: Review Published on: 29 October 2010
- View Full Text
- View PDF
Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions

With the advent of advances in biomarker detection and neuropsychological measurement, prospects have improved for identifying and tracking the progression of Alzheimer's disease (AD) from its earliest stages ...

Authors: Larry G Brooks and David A Loewenstein

Citation: Alzheimer's Research & Therapy 2010 2:28

Content type: Review Published on: 29 September 2010
- View Full Text
- View PDF

Prevention trials

Prevention of Alzheimer's disease in high risk groups: statin therapy in subjects with PSEN1 mutations or heterozygosity for apolipoprotein E epsilon 4

Assessing the progression of mild cognitive impairment to Alzheimer's disease: current trends and future directions